ACR Meeting Abstracts

ACR Meeting Abstracts

  • Meetings
    • ACR Convergence 2024
    • ACR Convergence 2023
    • 2023 ACR/ARP PRSYM
    • ACR Convergence 2022
    • ACR Convergence 2021
    • ACR Convergence 2020
    • 2020 ACR/ARP PRSYM
    • 2019 ACR/ARP Annual Meeting
    • 2018-2009 Meetings
    • Download Abstracts
  • Keyword Index
  • Advanced Search
  • Your Favorites
    • Favorites
    • Login
    • View and print all favorites
    • Clear all your favorites
  • ACR Meetings

Abstract Number: 2015

Ultrasonographyc Evaluation of Metacarpophalangeal Joints Can be Useful in the Differential Diagnosis of Early Rheumatoid Arthritis and  Early Spondyloarthritis. Α Monocentric Preliminary Study

Alberto Batticciotto1, Giada Prato2, Marco Antivalle2, Maria Chiara Ditto1, Maria Chiara Gerardi2, Rossella Talotta2, Federica Rigamonti2, Fabiola Atzeni1 and Piercarlo Sarzi-Puttini2, 1Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milano, Italy, 2Rheumatology Unit, ASST Fatebenefratelli - Sacco, L. Sacco University Hospital, Milan, Italy

Meeting: 2017 ACR/ARHP Annual Meeting

Date of first publication: September 18, 2017

Keywords: Early Rheumatoid Arthritis, spondylarthritis and ultrasonography

  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print
Session Information

Date: Tuesday, November 7, 2017

Title: Imaging of Rheumatic Diseases Poster II

Session Type: ACR Poster Session C

Session Time: 9:00AM-11:00AM

Background/Purpose: A number of studies have demonstrated that musculoskeletal ultrasonography (MSUS) is more sensitive in diagnosing arthritis than clinical examination although, as underlined in a recent review, it remains controversial whether it can substantially improve discrimination in the setting of early arthritis (EA). In 2011, Gutierrez et al. published preliminary data showing a high frequency of peritenon extensor tendon inflammation in patients with psoriatic arthritis (PsA), thus suggesting the potentially important role of US in the differential diagnosis of rheumatoid arthritis (RA) and PsA at metacarpophalangeal (MCP) joint level, and recommending additional research in order to confirm these data.Aim was to compare MSUS findings at MCP joint level in patients with early RA and early spondyloarthritis (SpA).

Methods: We retrospectively selected 35 patients who had been definitely diagnosed as having RA (2010 ACR/EULAR criteria) or axial/peripheral SpA (2009 ASAS criteria) within one year of their first visit from a consenting cohort of EA patients attending our Rheumatology Department between November 2012 and July 2016. Their demographic, clinical data and baseline MCP/wrist MSUS assessment data were recorded during the patients’ first visit to our EA clinic by an experienced rheumatologist and a blinded experienced sonographer. All of the patients were scanned using an ESAOTE MyLAB 70 equipped with a 6-18 MHz linear array transducer, and the findings were scored in accordance with the OMERACT guidelines.

Results:

The MSUS data of 20 RA patients (17 females and three males; median age 59 years, range 35-83 years; median time to a definite diagnosis 2.4 months, range 1-11 months) and 15 SpA patients (nine females and six mles; median age 53 years range, 18-78 years; median time to definite diagnosis 1.7 months, range 1-8 months) were retrospectively analysed. At the time of their first visit at the EA clinic, all of the patients had at least one MCP joint with synovial fluid and/or synovial hypertrophy with a grey scale (GS) score of >1, and there were no statistically significant differences in the percentages of patients presenting at least one power Doppler(PD)-positive joint (55% of RA and 53% of SpA patients; p= 0.92) and PD-positive tenosynovitis of the flexor tendons in at least one finger (10% of RA and 33% of SpA patients; p= 0.08). There was a statistically significant difference in the percentage of patients with erosion in at least one MCP (25% of RA and 0% of SpA patients; p=0.036) and in the percentage of patients with PD-positive paratenonitis of the extensor tendons in at least one finger (30% of RA and 80% of SpA patients; p= 0.003).

Conclusion: The patients with early RA showed a statistically higher percentage of erosions at the MCP MSUS evaluation of their first visit to the EA clinic than the patients with early SpA, who presented a higher percentage of PD-positive paratenonitis at the level of the extensor tendons than the patients with early RA. Larger studies are required to confirm the potential role of MCP MSUS in the differential diagnosis of early RA and early SpA.


Disclosure: A. Batticciotto, None; G. Prato, None; M. Antivalle, None; M. C. Ditto, None; M. C. Gerardi, None; R. Talotta, None; F. Rigamonti, None; F. Atzeni, None; P. Sarzi-Puttini, None.

To cite this abstract in AMA style:

Batticciotto A, Prato G, Antivalle M, Ditto MC, Gerardi MC, Talotta R, Rigamonti F, Atzeni F, Sarzi-Puttini P. Ultrasonographyc Evaluation of Metacarpophalangeal Joints Can be Useful in the Differential Diagnosis of Early Rheumatoid Arthritis and  Early Spondyloarthritis. Α Monocentric Preliminary Study [abstract]. Arthritis Rheumatol. 2017; 69 (suppl 10). https://acrabstracts.org/abstract/ultrasonographyc-evaluation-of-metacarpophalangeal-joints-can-be-useful-in-the-differential-diagnosis-of-early-rheumatoid-arthritis-and-early-spondyloarthritis-%ce%b1-monocentric-preliminary-st/. Accessed .
  • Tweet
  • Click to email a link to a friend (Opens in new window) Email
  • Click to print (Opens in new window) Print

« Back to 2017 ACR/ARHP Annual Meeting

ACR Meeting Abstracts - https://acrabstracts.org/abstract/ultrasonographyc-evaluation-of-metacarpophalangeal-joints-can-be-useful-in-the-differential-diagnosis-of-early-rheumatoid-arthritis-and-early-spondyloarthritis-%ce%b1-monocentric-preliminary-st/

Advanced Search

Your Favorites

You can save and print a list of your favorite abstracts during your browser session by clicking the “Favorite” button at the bottom of any abstract. View your favorites »

All abstracts accepted to ACR Convergence are under media embargo once the ACR has notified presenters of their abstract’s acceptance. They may be presented at other meetings or published as manuscripts after this time but should not be discussed in non-scholarly venues or outlets. The following embargo policies are strictly enforced by the ACR.

Accepted abstracts are made available to the public online in advance of the meeting and are published in a special online supplement of our scientific journal, Arthritis & Rheumatology. Information contained in those abstracts may not be released until the abstracts appear online. In an exception to the media embargo, academic institutions, private organizations, and companies with products whose value may be influenced by information contained in an abstract may issue a press release to coincide with the availability of an ACR abstract on the ACR website. However, the ACR continues to require that information that goes beyond that contained in the abstract (e.g., discussion of the abstract done as part of editorial news coverage) is under media embargo until 10:00 AM ET on November 14, 2024. Journalists with access to embargoed information cannot release articles or editorial news coverage before this time. Editorial news coverage is considered original articles/videos developed by employed journalists to report facts, commentary, and subject matter expert quotes in a narrative form using a variety of sources (e.g., research, announcements, press releases, events, etc.).

Violation of this policy may result in the abstract being withdrawn from the meeting and other measures deemed appropriate. Authors are responsible for notifying colleagues, institutions, communications firms, and all other stakeholders related to the development or promotion of the abstract about this policy. If you have questions about the ACR abstract embargo policy, please contact ACR abstracts staff at [email protected].

Wiley

  • Online Journal
  • Privacy Policy
  • Permissions Policies
  • Cookie Preferences

© Copyright 2025 American College of Rheumatology